☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
AbbVie
AbbVie and Simcere Zaiming Collaborate to Develop SIM0500 for Treating Multiple Myeloma
January 15, 2025
AbbVie to Bolster its Immunology Pipeline Through the Acquisition of Nimble Therapeutics
December 16, 2024
AbbVie Reports Results from the P-III (TEMPO-2) Study of Tavapadon for Parkinson's Disease
December 10, 2024
AbbVie and Genmab Highlight P-I/II (EPCORE NHL-2) Study Data of Epcoritamab to Treat R/R Follicular Lymphoma (FL) at ASH 2024
December 9, 2024
AbbVie’s Elahere (Mirvetuximab Soravtansine) Receives the EC’s Approval to Treat Platinum-Resistant Ovarian Cancer
November 18, 2024
AbbVie Reports the P-II (EMPOWER) Studies Data of Emraclidine for Treating Schizophrenia
November 12, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.